BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 25, 2015
View Archived Issues
Inhibition of ADAM 8 decreases pancreatic tumor burden and metastasis
Read More
Analysis of SNPs associates cannabinoid dependence and depression
Read More
New solifenacin succinate oral formulation for pediatric use
Read More
University of Texas System patent describes new antineogenic agents
Read More
Zhejiang Medicine synthesizes Akt, PI3K and PDGFRbeta inhibitors
Read More
Arrien Pharmaceuticals reports development of retinoid RORgammaT receptor antagonists
Read More
Aeglea Biotherapeutics raises funds to develop enzyme therapies for metabolic diseases and cancer
Read More
Novel PET radiotracer provides direct measure of PKM2 expression in vivo
Read More
Genetech presents novel PAK 1 inhibitors
Read More
Hangzhou DAC Biotech reports development of novel tubulysin analogues
Read More
Glyxambi tablets now available in the U.S.
Read More
Cipher Pharmaceuticals acquires Canadian rights to novel treatment for psoriasis and RA
Read More
Karos Pharmaceuticals patents TPH1 inhibitors
Read More
Alios BioPharma develops new antiviral compounds
Read More
MEI Pharma reports topline data from randomized phase II study of pracinostat
Read More
Sirona Biochem reports data for SBM-TFC-837 for antiaging and regenerative medicine
Read More
Bristol-Myers Squibb and ZAI Lab enter licensing agreement to develop brivanib in China
Read More
Immunovaccine begins phase II trial of DPX-Survivac immunotherapy in lymphoma
Read More
Teikoku Pharma seeks FDA approval for non-alcohol formula of docetaxel
Read More
Opicapone shows safety and efficacy as an add-on to levodopa in PD patients
Read More
EMA grants orphan status to Kamada treatment for graft-versus-host disease
Read More
TB Alliance awarded Australian grant to advance STAND trial and other programs
Read More
Ascletis announces results of a phase II study with danoprevir for hepatitis C virus infection
Read More
EMA grants orphan drug designation to Reolysin for gynecological cancers
Read More